Thalidomide does not improve survival in lung cancer
JNCI news brief: Thalidomide does not improve survival in small cell lung cancer – Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.